Form 4: MaxCyte Director Stanley C. Erck Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Director Stanley C. Erck of MaxCyte, Inc. exercised stock options and sold shares of common stock on September 3rd and 4th, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On September 3rd and 4th, 2024, Stanley C. Erck, a director of MaxCyte, Inc., executed stock options and sold shares of common stock.
- These transactions were carried out under a Rule 10b5-1 trading plan adopted on March 12, 2024.
- On September 3rd, Erck acquired 17,922 shares at $0.04 per share and sold the same amount at a weighted average price of $4.1, with prices ranging from $4.04 to $4.30.
- On September 4th, he acquired 29,767 shares at $0.04 per share and sold the same amount at a weighted average price of $3.97, with prices ranging from $3.90 to $4.07.
- Following these transactions, Erck directly owns 269,118 shares of common stock.
- He also holds options to buy 95,378 shares of common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing trading plan. There is no indication of positive or negative sentiment towards the company's prospects.
Industry Context
Form 4 filings are standard disclosures for corporate insiders and provide transparency into their trading activities. The use of a 10b5-1 trading plan indicates that these transactions were pre-planned and not based on any material non-public information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increase in the number of shares sold in the market.
- The impact on other stakeholders is likely to be minimal.
Key Dates
| Date | Description |
|---|---|
| 2024/03/12 | Date of adoption of Rule 10b5-1 trading plan. |
| 2024/09/03 | Date of first transaction: exercise of options and sale of shares. |
| 2024/09/04 | Date of second transaction: exercise of options and sale of shares. |
| 2024/09/05 | Date of signature on the Form 4 filing. |
| 2024/11/11 | Expiration date of the employee stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.